Topics

Companies Related to "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" [Most Relevant Company Matches] RSS

18:23 EST 9th December 2019 | BioPortfolio

Here are the most relevant search results for "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" found in our extensive corporate database of over 50,000 company records.

Showing "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" Companies 1–25 of 1,600+

Extremely Relevant

XDx, Inc.

Based in Brisbane, California, XDx is a molecular diagnostics company focused on the discovery, development and commercialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. The company has developed a proprietary new method for noninvasively monitoring immune system activity by measuring g...


Gold Standard/Elsevier

Based in Tampa, FL, Gold Standard/ELSEVIER uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/ELSEVIER solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To...

Elsevier and Gold Standard Elsevier

Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. ...


Elsevier and Gold Standard/Elsevier

Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. ...

Relevant

Gold Standard Diagnostics, Inc.

Gold Standard Diagnostics is a pioneer in providing products and services to the medical diagnostic industry. We partner with reagent and equipment manufacturers from around the world, creating innovative and cost effective diagnostics solutions for clinical and hospital laboratories. Gold Standard also develops its own suite of proprietary products that p...

Gold Standard Diagnostics Corp.

Gold Standard Diagnostics, Corp. is a clinical diagnostics company based in Davis, California. The company develops, manufactures and distributes a portfolio of instrumentation and diagnostic test kits to clinical laboratories worldwide. In addition to the AIX1000, current product offerings include the Thunderbolt™ and Bolt®, open format instrume...

Gold Standard

Founded in 1993, Tampa, Florida-based Gold Standard is a leading developer of drug information databases, software, and clinical information solutions. Our products are developed by a staff of highly trained professionals with extensive experience in pharmacy practice, electronic publishing and software development. Gold Standard’s customers include hundreds of hospitals, the nation’s largest ...

SangStat Medical Corporation

SangStat, The Transplant Company(R), is a specialty pharmaceutical company applying a disease management approach to improve the outcome of organ transplantation. The Company's devices, drugs and services form a family of products that address the needs of patients in each stage of transplant care from pre-transplant monitoring to lifetime post-transplant care. SangStat's product pipeline is a com...

The CEO Roundtable on Cancer

The CEO Roundtable on Cancer was founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded with the CEO Cancer Gold Standard encouraging its widespread adoption in workplaces across the country. For more information on t...

Lycera Corp.

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease and transplant rejection. Originally founded by Dr. Gary Glick as a spin-out of the University of Michigan, Lycera is developing drug candidates that target two novel therape...

Aquila Diagnostic Systems Inc.

Aquila Diagnostic Systems Inc.’s patented Accutas technology allows gold-standard molecular diagnostic (DNA/RNA) tests to be performed at a veterinary clinic or in the field using non-standard mediums such as fecal material with a sample-to-results time of 2 hours or less. Accutas molecular diagnostic tests may be performed on any Aquila-certified ind...

World Gold Council

World Gold Council's mission is to stimulate and sustain the demand for gold and to create enduring value for its stakeholders. It is funded by the world's leading gold mining companies. For further information please visit http://www.gold.org.

Transplant Genomics Inc.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes. Working with the transplant community, TGI will bring vital advances in diagnosis and prediction of transplant status from bench to clinic, supporting clinicians with clear, actionable information to optimize immunosuppression therapy, enhance patient c...

GOLD STANDARD and ELSEVIER

British BioCell International

BBInternational - Experts in reagent supply, assay development and contract manufacture. Our unique formula gold and silver colloids are widely regarded within the Diagnostic and Research industries as the "Gold Standard", due to their spherical nature, mono dispersity and stringent size specifications. This makes BBInternational colloids ideal for use in applications where consistent shape and s...

Guidry & East

Welcome! Thank you for visiting Guidry & East's website. We offer expert consulting services to Transplant Centers to bring efficiency, improve financial results, and enhance quality patient care.Our consulting team has collectively over 150 years of Clinical Transplant experience and includes experienced Transplant Administrators who have been responsible for gross revenues of over $200 million. ...

GPRD Exellence in Public Health Research

The GPRD Division is a dedicated multi-disciplinary team based at the Medicines & Healthcare products Regulatory Agency (MHRA) in London who operate the General Practice Research Database, the GOLD standard of longitudinal anonymised patient databases from primary care.Our mission is simple...to promote and protect public health by establishing the GPRD as the premier source of longitudinal patien...

Gold?s Gym

Established in Venice, Calif. in 1965, Gold's Gym is the largest co-ed gym chain in the world with over 620 locations in 43 states and 30 countries. Gold's Gym offers the latest equipment and services, including group exercise, personal training, cardiovascular equipment, spinning, Pilates and yoga. With nearly 3 million members worldwide, Gold's Gym continues to change lives by helping people ach...

Glycorex Transplantation AB

Glycorex Transplantation AB (publ.) markets products that decrease the risk of graft-rejection. The products facilitate an increased number of transplants.The company was founded in 1996 by Dr. Kurt Nilsson and is located in Lund in southern Sweden.The company market products enabling an increased number of transplants. The products are clinically used enabling ABO-incompatible transplants at seve...

Alulim Pharma, Inc.

Alulim Pharma, Inc. is a privately held biotechnology company delivering aerosolized therapeutic medications. The company’s products treat transplant rejection, asthma, COPD and cancer. All the company’s products are unique to them and protected by international patents. With over 25 years of aerosol and clinical experience, Alulim’s seasoned ...

Kona Gold Solutions, Inc.

Kona Gold Solutions, Inc., a Delaware Corporation, has created wholly owned subsidiaries, Kona Gold LLC, HighDrate, LLC, and Gold Leaf Distribution, LLC. Kona Gold, LLC has developed a premium Hemp Infused Energy Drink line; please visit the Company’s website at www.konagoldhemp.com. HighDrate, LLC has developed the beverage industry’s first CBD Energy...

Gold's Gym

Established in Venice, Calif. in 1965, Gold's Gym is the largest full service gym chain in the world with more than 700 locations in 43 states and 28 countries. Gold's Gym offers the latest equipment and services, including group exercise, personal training, cardiovascular equipment, group cycle, Pilates and yoga. With nearly 3.5 million members worldwide, Gold's Gym helps all kinds of people ac...

NephroPath

Time to diagnosis can have a critical effect on the ultimate outcome of many renal diseases, and when a patient undergoes an invasive procedure such as a renal biopsy, there can be significant anxiety while the results are pending. Over the last 14 years, Dr. Patrick Walker, our Director and one of the nation's leading renal pathologists, has developed a unique system for rapid processing of renal...

Transplant Connect

Transplant Connect is an innovative medical software firm that specializes in electronic medical record and clinical information systems for the organ, tissue and eye transplant field. It was founded in 2003, with the mission of improving and increasing transplantation through modern software and communications. The iTransplantSM Platform is a web-centr...

TAI Diagnostics, Inc.

TAI Diagnostics was founded in 2015 to further develop and commercialize cell-free DNA technology licensed from the Medical College of Wisconsin for monitoring the health of transplanted organs. TAI provides testing services through their CLIA/CAP accredited Clinical Reference Laboratory in Milwaukee, Wisconsin. The myTAIHEART® test is available for use in post-transplant monitoring of pediatr...


More From BioPortfolio on "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection"

Quick Search

Corporate Database Quicklinks